NewsRx

Search our medical news database

Ovarian Cancer

Study Results Support Progestin Use To Reduce Risk

Published in Women's Health Weekly, March 22nd, 2001

Medical prevention of ovarian cancer may be possible for all women in the future, according to Duke Comprehensive Cancer Center researchers in North Carolina.

They report finding a second biologic pathway in monkeys that helps explain birth control pills' protective effect against ovarian cancer.

The results of new laboratory research indicate that the pills' protective effect is not due solely to preventing ovulation, suggesting that chemoprevention of ovarian cancer could be extended to women who are not ovulating or who are not interested in contraception, said Dr. Gustavo Rodriguez. He prepared the study findings for presentation March 4,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook